The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients

Stellbrink, HJ; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S

doi:10.1186/1758-2652-13-S4-O47

Journal of the International AIDS Society

Article metrics
Last updated: Sat, 27 Apr 2024 2:43:03 Z

The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients

Access & Citations

1152

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.